Company: ZDAN
Filing Date: 2025-07-28
Form Type: F-1/A
Source: 0001683168-25-005450
Chunk: 123

Company: Zerolimit Technology Holding Co. Ltd.
Filing Date: 2025-07-28
Form: F-1/A
Chunk 123
---
 all of the periodic disclosure, current reporting requirements
and shareholder proxy rules of the Exchange Act. The determination of foreign private issuer status is made annually on the last business
day of an issuer’s most recently completed second fiscal quarter. We would lose our foreign private issuer status if, for example,
more than 50% of our Ordinary Shares are directly or indirectly held by residents of the U.S. and we fail to meet additional requirements
necessary to maintain our foreign private issuer status. If we lose our foreign private issuer status, we will be required to file with
the SEC periodic reports and registration statements on U.S. domestic issuer forms, which are more detailed and extensive than the forms
available to a foreign private issuer. We will also have to mandatorily comply with U.S. federal proxy requirements, and our officers,
directors and principal shareholders will become subject to the short-swing profit disclosure and recovery provisions of Section 16
of the Exchange Act. In addition, we will lose our ability to rely upon exemptions from certain corporate governance requirements under
the Nasdaq listing rules. As a U.S. public company that is not a foreign private issuer, we will incur significant additional legal,
accounting and other expenses that we would not incur as a foreign private issuer, in order to maintain a listing on a U.S. securities
exchange.

| 64 |

You must rely on the judgment of our management as to the use of the net proceeds from this offering, and such use may not produce income or increase the price of our Ordinary Shares.

Our management will have
considerable discretion in the application of the net proceeds received by us. You will not have the opportunity, as part of your investment
decision, to assess whether proceeds are being used appropriately. The net proceeds may be used for corporate purposes that do not improve
our efforts to maintain profitability or increase the Ordinary Share price. For instance, the net proceeds from this offering may be
placed in research and development projects that do not produce income or do not lead to finished products.

Some members of our management team lack experience in managing a U.S. publicly-listed company which may adversely affect our business, financial conditions, and results of operations.

Some members of our current
management team lack experience in managing a company publicly traded in the U.S., interacting with public company investors, and complying
with the increasingly complex laws pertaining to U.S.-listed public companies. Although they are aware of the availability of U.S. counsel
to advise them regarding these laws and regulations